Russell Investments Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.1K | Buy |
2,241
+228
| +11% | +$3.98K | ﹤0.01% | 3038 |
|
|
2025
Q1 | $25.3K | Buy |
2,013
+1,096
| +120% | +$13.8K | ﹤0.01% | 3058 |
|
|
2024
Q4 | $9.67K | Sell |
917
-30,760
| -97% | -$325K | ﹤0.01% | 3139 |
|
|
2024
Q3 | $459K | Buy |
31,677
+2,690
| +9% | +$39K | ﹤0.01% | 2302 |
|
|
2024
Q2 | $247K | Buy |
28,987
+23,090
| +392% | +$196K | ﹤0.01% | 2425 |
|
|
2024
Q1 | $60.3K | Buy |
+5,897
| New | +$60.3K | ﹤0.01% | 2644 |
|
|
2023
Q2 | – | Sell |
-7,476
| Closed | -$48.7K | – | 3524 |
|
|
2023
Q1 | $48.7K | Sell |
7,476
-160
| -2% | -$1.04K | ﹤0.01% | 2717 |
|
|
2022
Q4 | $65.1K | Buy |
7,636
+638
| +9% | +$5.44K | ﹤0.01% | 2718 |
|
|
2022
Q3 | $36K | Sell |
6,998
-1,414
| -17% | -$7.27K | ﹤0.01% | 2768 |
|
|
2022
Q2 | $35K | Buy |
+8,412
| New | +$35K | ﹤0.01% | 2755 |
|